Serotonin (5‐Hydroxytryptamine): Metabolism, Signaling, Biological Functions, Diseases, and Emerging Therapeutic Opportunities
MedComm · 2025-09 · 6 (9)
DOI: 10.1002/mco2.70383 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 09.09.2025. Verfasst von Yuxin Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology Department of General Surgery Nanjing Drum Tower Hospital The Affiliated Hospital of Medical Sch…. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 614 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Serotonin (5‐hydroxytryptamine; 5‐HT) is an evolutionarily conserved monoamine neurotransmitter that plays critical roles in various physiological systems, functioning as a neurotransmitter, hormone, and paracrine signaling molecule. This review synthesizes current research on 5‐HT metabolism (biosynthesis, transport, and degradation), 5‐HT receptor‐mediated signaling pathways (seven receptor families and 14 subtypes), and broad biological functions of 5‐HT. We emphasize the roles of 5‐HT in both health and disease, with a particular focus on its emerging significance in the tumor immune microenvironment. Studies have shown that dysregulated 5‐HT signaling is associated with various pathological conditions, including functional gastrointestinal disorders, psychiatric diseases, metabolic disorders, and cancer progression. Notably, this review describes novel mechanisms by which 5‐HT modulates tumor immunity, including its effects on macrophage polarization, dendritic cell function, T cell activity, and PD‐L1 expression, and it explores the therapeutic potential of targeting 5‐HT‐associated pathways. Promising therapeutic strategies that target 5‐HT include combining selective serotonin reuptake inhibitors with immune checkpoint inhibitors, inhibiting key metabolic enzymes (e.g., Tph1 and MAO‐A), and developing receptor subtype‐specific agents (e.g., 5‐HT 7 R antagonists). These findings position the 5‐HT system as a pivotal target for next‐generation precision therapeutics across multiple disease domains.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Pharmaceutical Biotechnology Department of General Surgery Nanjing Drum Tower Hospital The Affiliated Hospital of Medical School Medical School Nanjing University Nanjing China.
- Jinan Microecological Biomedicine Shandong Laboratory Building 1, Jinan Medical and Health Science and Technology Innovation Industrial Park Jinan City Shandong China.
- Dezhou Hospital of Traditional Chinese Medicine Dezhou China.
- "Nanjing University-Gulou" Joint Laboratory of AI and Healthcare Bigdata National Institute of Healthcare Data Science at Nanjing University School of Life Sciences Jiangsu Key Laboratory of Molecular Medicine Nanjing U…
- Department of Hepatobiliary and Pancreatic Surgery The Second Affiliated Hospital of Fujian Medical University Fuzhou China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Y., Wang, N., Zhang, L., Zhuang, Y., Xin, Q., Gu, X., Jiang, C., & Wu, J. (2025). Serotonin (5‐Hydroxytryptamine): Metabolism, Signaling, Biological Functions, Diseases, and Emerging Therapeutic Opportunities. MedComm, 6(9). https://doi.org/10.1002/mco2.70383
Vancouver
Zhang Y, Wang N, Zhang L, Zhuang Y, Xin Q, Gu X, et al. Serotonin (5‐Hydroxytryptamine): Metabolism, Signaling, Biological Functions, Diseases, and Emerging Therapeutic Opportunities. MedComm. 2025;6(9). doi:10.1002/mco2.70383
BibTeX
@article{Zhang2025,
author = {Zhang, Yuxin and Wang, Nan and Zhang, Louqian and Zhuang, Yan and Xin, Qilei and Gu, Xiaosong and Jiang, Chunping and Wu, Junhua},
title = {Serotonin (5‐Hydroxytryptamine): Metabolism, Signaling, Biological Functions, Diseases, and Emerging Therapeutic Opportunities},
journal = {MedComm},
year = {2025},
volume = {6},
number = {9},
doi = {10.1002/mco2.70383}
}
EUVIMED